Research programme: osteoporosis therapies - PhosphagenicsAlternative Names: Parathyroid hormone fragments - Phosphagenics; TPM 01/PTH
Latest Information Update: 23 Feb 2010
At a glance
- Originator Phosphagenics
- Class Peptide hormones
- Mechanism of Action Parathyroid hormone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 24 Aug 2005 Preclinical trials in Osteoporosis in Australia (Transdermal)